Overview
Following subcutaneous injection, BPC-157 distributes rapidly with a ~4-hour half-life and exhibits preferential bioavailability at mucosal surfaces, tendons, and the gut-brain axis. GHK-Cu has a shorter plasma half-life (~1–2 hours) but demonstrates prolonged local tissue effects through receptor-mediated endocytosis and nuclear translocation, modulating chromatin remodeling. TB-500's actin-binding mechanism creates a sustained depot effect, with Thymosin Beta-4 protein exhibiting a half-life measured in days in some tissue compartments. All three peptides avoid hepatic first-pass metabolism via subcutaneous administration, maximizing bioavailability.
Proposed mechanism
BPC-157 modulates the nitric oxide system and upregulates growth factor receptors (VEGFR2, EGFR) to promote angiogenesis and tissue repair. GHK-Cu (copper tripeptide) activates over 4,000 genes related to collagen and elastin production, antioxidant defense, and anti-inflammatory signaling via activation of the proteasome and TGF-β pathways. TB-500 (Thymosin Beta-4) sequesters G-actin to regulate actin polymerization, promoting cell migration, differentiation, and vascular repair through upregulation of Thymosin Beta-4 and its downstream effectors including integrin-linked kinase.
What the evidence supports
Most data comes from preclinical animal studies. Human clinical trial evidence is limited or absent.
Graded Animal
Evidence drawn from in vivo animal models or in vitro systems. Mechanistically informative; translation to humans is unproven.
Key citations
Representative primary sources, including results that did not favour the compound.
- [1]
Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract
· Current Pharmaceutical Design, Sikiric et al., PMID: 27138887 · 2016
- [2]
Human skin remodeling peptide GHK-Cu and skin gene regulation
· Oxidative Medicine and Cellular Longevity, Pickart L & Margolina A, DOI: 10.1155/2015/648108 · 2015
- [3]
Thymosin beta4 and its role in wound healing and tissue repair
· Annals of the New York Academy of Sciences, Goldstein AL & Kleinman HK, DOI: 10.1111/j.1749-6632.2009.05375.x · 2010
- [4]
The actin-sequestering protein thymosin-β4 promotes angiogenesis, wound healing, and tissue regeneration
· FASEB Journal, Bock-Marquette I et al., DOI: 10.1096/fj.04-3134fje · 2005
Citation records in this build are illustrative placeholders for the design.
Reference information for research purposes. Not medical advice, and not a recommendation to use any compound. Many entries describe substances that are not approved for human use.